Neurointervention.  2019 Mar;14(1):61-62. 10.5469/neuroint.2019.00059.

Commentary to: Efficacy of Percutaneous Sclerotherapy in Low Flow Venous Malformations - A Single Center Series

• Lee J

• KMID: 2446783
• DOI: http://doi.org/10.5469/neuroint.2019.00059

Abstract

No abstract available.

MeSH Terms

Sclerotherapy*

Reference

1. Ahmad S. Efficacy of percutaneous sclerotherapy in low flow venous malformations - a single center series. Neurointervention. 2019; 14:53–60.

2. Dasgupta R, Fishman SJ. ISSVA classification. Semin Pediatr Surg. 2014; 23:158–161.

3. Mendonca DA, McCafferty I, Nishikawa H, Lester R. Venous malformations of the limbs: the Birmingham experience, comparisons and classification in children. J Plast Reconstr Aesthet Surg. 2010; 63:383–389.

4. Behravesh S, Yakes W, Gupta N, Naidu S, Chong BW, Khademhosseini A, et al. Venous malformations: clinical diagnosis and treatment. Cardiovasc Diagn Ther. 2016; 6:557–569.

5. Ali S, Mitchell SE. Outcomes of venous malformation sclerotherapy: a review of study methodology and long-term results. Semin Intervent Radiol. 2017; 34:288–293.

6. Hammer J, Seront E, Duez S, Dupont S, Van Damme A, Schmitz S, et al. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study. Orphanet J Rare Dis. 2018; 13:191.

7. Kim JB, Lee JW, Choi KY, Yang JD, Cho BC, Lee SJ, et al. Clinical characteristics of arteriovenous malformations of the head and neck. Dermatol Surg. 2017; 43:526–533.